Psychiatric Status Rating Scales

• 

  Subject Areas on Research

  • "Code stroke": hospitalized versus emergency department patients. 
  • A 2-year follow-up of social phobia. Status after a brief medication trial. 
  • A 3-year longitudinal study examining the effect of resilience on suicidality in veterans. 
  • A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept. 
  • A Brief Interview to Detect Panic Attacks and Panic Disorder in Emergency Department Patients with Cardiopulmonary Complaints. 
  • A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample. 
  • A New Severity Scoring Scale for the 3-Minute Confusion Assessment Method (3D-CAM). 
  • A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. 
  • A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A brief history of psychiatric classification. From the ancients to DSM-IV. 
  • A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology. 
  • A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. 
  • A comparative evaluation of three discriminant scales for endogenous depression. 
  • A comparison of alternative assessments of depressive symptom severity: a pilot study. 
  • A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. 
  • A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. 
  • A comparison of normal forgetting, psychopathology, and information-processing models of reported amnesia for recent sexual trauma. 
  • A comparison of self-reported versus clinician-related symptoms in depression. 
  • A descriptive analysis of minor depression. 
  • A double-blind comparison of bupropion and amitriptyline in depressed inpatients. 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. 
  • A fidelity measure for integrated management of depression in primary care. 
  • A genetically informed study of the longitudinal relation between irritability and anxious/depressed symptoms. 
  • A longitudinal study of gender differences in depressive symptoms from age 50 to 80. 
  • A meta-analysis of the relationship between symptom severity of Posttraumatic Stress Disorder and executive function. 
  • A modified DBT skills training program for oppositional defiant adolescents: promising preliminary findings. 
  • A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. 
  • A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. 
  • A multivariate analysis of factors associated with depression: evaluating the role of health literacy as a potential contributor. 
  • A national study of violent behavior in persons with schizophrenia. 
  • A naturalistic, multi-site study of repetitive transcranial magnetic stimulation therapy for depression. 
  • A pilot study of a structured interview addressing sexual function in men with schizophrenia. 
  • A pilot study of mirtazapine in post-traumatic stress disorder. 
  • A placebo-controlled study of Kava kava in generalized anxiety disorder. 
  • A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. 
  • A prospective study of depression following combat deployment in support of the wars in Iraq and Afghanistan. 
  • A prospective study of firefighters' PTSD and depression symptoms: The first 3 years of service. 
  • A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. 
  • A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder. 
  • A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder. 
  • A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. 
  • A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder. 
  • A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). 
  • A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. 
  • A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. 
  • A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. 
  • A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. 
  • A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. 
  • A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. 
  • A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. 
  • A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. 
  • A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. 
  • A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. 
  • A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life. 
  • A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia. 
  • A systematic review of the PTSD Checklist's diagnostic accuracy studies using QUADAS. 
  • A test of whether coping styles moderate the effect of PTSD symptoms on alcohol outcomes. 
  • A three-factor analytic model of the MADRS in geriatric depression. 
  • A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative. 
  • ACP Journal Club: review: in primary care, screening with the GAD-7 detected anxiety disorder; the PHQ detected panic disorder. 
  • APOE epsilon4 and low cholesterol as risks for depression in a biracial elderly community sample. 
  • Abnormal functional connectivity in autism spectrum disorders during face processing. 
  • Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. 
  • Accuracy of a Proactive Case Detection Tool for Internalizing and Externalizing Problems Among Children and Adolescents. 
  • Accuracy of proactive case finding for mental disorders by community informants in Nepal. 
  • Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. 
  • Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study. 
  • Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. 
  • Adolescent outcomes of childhood disorders: the consequences of severity and impairment. 
  • Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. 
  • Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up. 
  • Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome. 
  • Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. 
  • Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. 
  • Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. 
  • Adult psychiatric outcomes of bullying and being bullied by peers in childhood and adolescence. 
  • Adverse race-related events as a risk factor for posttraumatic stress disorder in Asian American Vietnam veterans. 
  • Age and impaired subjective support. Predictors of depressive symptoms at one-year follow-up. 
  • Age differences in symptom expression in patients with major depression. 
  • Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. 
  • Age of onset for binge eating: Are there different pathways to binge eating? 
  • Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis. 
  • Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients. 
  • Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. 
  • Alcohol abuse and dependence in the rural South. 
  • Alcohol dependence and use of treatment services among women in the community. 
  • Alcohol use and trauma exposure among male and female veterans before, during, and after military service. 
  • Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. 
  • Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression. 
  • Alprazolam vs amitriptyline in depressions with reduced REM latencies. 
  • Amygdala reactivity and negative emotionality: divergent correlates of antisocial personality and psychopathy traits in a community sample. 
  • Amygdala volume in late-life depression: relationship with age of onset. 
  • Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. 
  • An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. 
  • An Electrophysiological Biomarker That May Predict Treatment Response to ECT. 
  • An assessment of the Newcastle Anxiety Depression Index. 
  • An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. 
  • An emerging schizophrenic syndrome. 
  • An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. 
  • An outpatient evaluation of phenelzine and imipramine. 
  • Antenatal thyroid correlates of postpartum depression. 
  • Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. 
  • Antipsychotic drug effects on brain morphology in first-episode psychosis. 
  • Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. 
  • Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). 
  • Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. 
  • Anxiety in youth with and without autism spectrum disorder: examination of factorial equivalence. 
  • Anxiety reduces baroreflex cardiac control in older adults with major depression. 
  • Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. 
  • Appetite loss and neurocognitive deficits in late-life depression. 
  • Are associations between parental divorce and children's adjustment genetically mediated? An adoption study. 
  • Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study. 
  • Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? 
  • Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. 
  • Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. 
  • Assessing Acute Secondary Treatment Outcomes in Early-Onset Obsessive-Compulsive Disorder. 
  • Assessing anxiety in youth with the multidimensional anxiety scale for children. 
  • Assessing anxious features in depressed outpatients. 
  • Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II). 
  • Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? 
  • Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. 
  • Assessment of a new self-rating scale for post-traumatic stress disorder. 
  • Association between APOE epsilon4 allele and vascular dementia: The Cache County study. 
  • Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. 
  • Association between depression severity and amygdala reactivity during sad face viewing in depressed preschoolers: an fMRI study. 
  • Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. 
  • Association of Childhood Trauma Exposure With Adult Psychiatric Disorders and Functional Outcomes. 
  • Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. 
  • Association of Parental Incarceration With Psychiatric and Functional Outcomes of Young Adults. 
  • Association of depression and survival in patients with chronic heart failure over 12 Years. 
  • Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure. 
  • Association of depressive symptoms with hippocampal volume in 1936 adults. 
  • Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. 
  • Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001. 
  • Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia. 
  • Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. 
  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis. 
  • BIS and BAS interact with perceived parental affectionless control to predict personality disorder symptomatology. 
  • Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. 
  • Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder. 
  • Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. 
  • Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. 
  • Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. 
  • Biological and cognitive predictors of response to acute treatment in depressed outpatients. 
  • Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV. 
  • Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial. 
  • Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. 
  • Brain volumes in psychotic youth with schizophrenia and mood disorders. 
  • Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. 
  • Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment. 
  • Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). 
  • Bulimia and depression. 
  • Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. 
  • Bupropion in the treatment of outpatients with asthma and major depressive disorder. 
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. 
  • Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial. 
  • Can psychopathic offenders discern moral wrongs? A new look at the moral/conventional distinction. 
  • Can women provide reliable information about their children's fathers? cross-informant agreement about men's lifetime antisocial behaviour. 
  • Candidate neuroanatomic substrates of psychosis in old-aged depression. 
  • Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans. 
  • Capgras syndrome in homocystinuria. 
  • Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men. 
  • Caregiving for persons with mental illness: the impact of outpatient commitment on caregiving strain. 
  • Catastrophizing, depression and the sensory, affective and evaluative aspects of chronic pain. 
  • Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity. 
  • Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • Cerebral microbleeds and neuropsychiatric symptoms in an elderly Asian cohort. 
  • Cerebral white matter disease in late-onset paranoid psychosis. 
  • Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression. 
  • Change in stress and social support as predictors of cognitive decline in older adults with and without depression. 
  • Change over a 12-month period in the psychological adjustment of children and adolescents with cystic fibrosis. 
  • Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. 
  • Changes in posttraumatic stress disorder and depressive symptoms during cognitive processing therapy: evidence for concurrent change. 
  • Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). 
  • Characteristics of neurocognitive functions in mild cognitive impairment with depression. 
  • Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. 
  • Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. 
  • Characteristics of very poor outcome schizophrenia. 
  • Child vs Adult Onset of Attention-Deficit/Hyperactivity Disorder-Reply. 
  • Child/Adolescent anxiety multimodal study: evaluating safety. 
  • Childhood neuropsychological deficits associated with adult obsessive-compulsive disorder. 
  • Childhood psychiatric disorders and young adult crime: a prospective, population-based study. 
  • Childhood sexual and physical abuse and the 1-year prevalence of medical problems in the National Comorbidity Survey. 
  • Children of currently depressed mothers: a STAR*D ancillary study. 
  • Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. 
  • Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. 
  • Children with major depression show reduced rapid eye movement latencies. 
  • Cholesterol and cognitive performance among community volunteers from the Czech Republic. 
  • Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. 
  • Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. 
  • Classifying insomnia in a clinically useful way. 
  • Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial. 
  • Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. 
  • Clinical and phenomenological comparisons of late-onset and early-onset depression. 
  • Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients. 
  • Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. 
  • Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. 
  • Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. 
  • Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. 
  • Clinical experience with substance P receptor (NK1) antagonists in depression. 
  • Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. 
  • Clinical features of depression in Asia: results of a large prospective, cross-sectional study. 
  • Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. 
  • Clinical outcomes of older depressed patients with and without comorbid neuroticism. 
  • Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. 
  • Clinician, parent, and child prediction of medication or placebo in double-blind depression study. 
  • Clinician-administered PTSD scale: a review of the first ten years of research. 
  • Clozapine decreases smoking in patients with chronic schizophrenia. 
  • Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. 
  • Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. 
  • Cognition as an outcome measure in schizophrenia. 
  • Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. 
  • Cognitive disparity in schizophrenics with and without cocaine dependency. 
  • Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. 
  • Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. 
  • Cognitive impairment and depression outcomes in the IMPACT study. 
  • Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. 
  • Cognitive sequelae of blast-related versus other mechanisms of brain trauma. 
  • Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood. 
  • Cognitive-behavioral therapy for PTSD and depression symptoms reduces risk for future intimate partner violence among interpersonal trauma survivors. 
  • Combined catecholamine and indoleamine depletion following response to ECT. 
  • Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. 
  • Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder. 
  • Community integration of formerly homeless men and women with severe mental illness after hospital discharge. 
  • Comorbid mental disorders: implications for treatment and sample selection. 
  • Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. 
  • Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. 
  • Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. 
  • Comorbidity between abuse of an adult and DSM-III-R mental disorders: evidence from an epidemiological study. 
  • Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Comparative diagnostic criteria for melancholia and endogenous depression. 
  • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. 
  • Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. 
  • Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. 
  • Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. 
  • Comparison of mental health between former child soldiers and children never conscripted by armed groups in Nepal. 
  • Comparison of older depressed hospitalized patients with and without heart failure/pulmonary disease. 
  • Comparison of the posttraumatic stress disorder scale versus the clinician-administered posttraumatic stress disorder scale in domestic violence survivors. 
  • Comparison of two brief tests of organic brain impairment, the MSQ and the short portable MSQ. 
  • Complex PTSD in victims exposed to sexual and physical abuse: results from the DSM-IV Field Trial for Posttraumatic Stress Disorder. 
  • Conceptual similarity promotes generalization of higher order fear learning. 
  • Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. 
  • Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. 
  • Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. 
  • Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. 
  • Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. 
  • Conflict and mental health: a cross-sectional epidemiological study in Nepal. 
  • Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB). 
  • Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. 
  • Controversies in community-based psychiatric epidemiology: let the data speak for themselves. 
  • Converting positive and negative symptom scores between PANSS and SAPS/SANS. 
  • Coping and thought suppression as predictors of suicidal ideation in depressed older adults with personality disorders. 
  • Coronary catherization patient and wife's perceptions of social support: effects due to characteristics of recipient, provider, and their interaction. 
  • Correlates of anger and hostility in Iraq and Afghanistan war veterans. 
  • Correlates of remission in primary care patients treated for minor depression. 
  • Cortisol responses to emotional stress in men: association with a functional polymorphism in the 5HTR2C gene. 
  • Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. 
  • Cross-cultural considerations in administering the center for epidemiologic studies depression scale. 
  • Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. 
  • Cumulative prevalence of psychiatric disorders by young adulthood: a prospective cohort analysis from the Great Smoky Mountains Study. 
  • D-amphetamine in obsessive-compulsive disorder 
  • Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults. 
  • Decreased between-hemisphere connectivity strength and network efficiency in geriatric depression. 
  • Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). 
  • Default mode network connectivity in children with a history of preschool onset depression. 
  • Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. 
  • Defining Treatment Response and Remission in Youth Anxiety: A Signal Detection Analysis With the Multidimensional Anxiety Scale for Children. 
  • Defining a cognitive function decrement in schizophrenia. 
  • Deliberate self-harm and suicidal ideation among male Iraq/Afghanistan-era veterans seeking treatment for PTSD. 
  • Delirium: the struggle to vanquish an ancient foe. 
  • Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. 
  • Dementia severity and pattern of cognitive performance in vascular dementia. 
  • Demographic and clinical characteristics associated with a history of bizarre delusions in a cross-diagnostic sample of individuals with psychotic disorders. 
  • Demographic characteristics do not decrease the utility of depressive symptoms assessments: examining the practical impact of item bias in four heterogeneous samples of older adults. 
  • Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. 
  • Depressed older patients with the atypical features of interpersonal rejection sensitivity and reversed-vegetative symptoms are similar to younger atypical patients. 
  • Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. 
  • Depressed pregnant black women have a greater incidence of prematurity and low birthweight outcomes. 
  • Depression Suppresses Treatment Response for Traumatic Loss-Related Posttraumatic Stress Disorder in Active Duty Military Personnel. 
  • Depression among women experiencing intimate partner violence in a Chinese community 
  • Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. 
  • Depression in elderly hospitalized patients with medical illness. 
  • Depression in long-term care. 
  • Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. 
  • Depression in patients with chronic kidney disease on dialysis in Saudi Arabia. 
  • Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study. 
  • Depression in primary caregivers of patients listed for liver or kidney transplantation. 
  • Depression inhibits the anti-inflammatory effects of leisure time physical activity and light to moderate alcohol consumption. 
  • Depression scale scores in 8-17-year-olds: effects of age and gender. 
  • Depression, suicidal ideation, and associated factors: a cross-sectional study in rural Haiti. 
  • Depressive Symptoms and Risk of Postoperative Delirium. 
  • Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. 
  • Depressive comorbidity in preschool anxiety disorder. 
  • Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. 
  • Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. 
  • Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator. 
  • Describing depression: congruence between patient experiences and clinical assessments. 
  • Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. 
  • Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. 
  • Detection of psychiatric disorders in pediatric primary care: a preliminary report. 
  • Developing a screening index for community studies of somatization disorder. 
  • Developing and validating a perinatal depression screening tool in Kenya blending Western criteria with local idioms: A mixed methods study. 
  • Development and Evaluation of the ADHD Cognitions Scale for Adults. 
  • Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. 
  • Development and validation of the Psychological Adaptation Scale (PAS): use in six studies of adaptation to a health condition or risk. 
  • Development of a computer-based behavioral assessment of checking behavior in obsessive-compulsive disorder. 
  • Development of substance use and psychiatric comorbidity in an epidemiologic study of white and American Indian young adolescents the Great Smoky Mountains Study. 
  • Development of the Yale Food Addiction Scale Version 2.0. 
  • Developmental epidemiology. 
  • Deviation from expected cognitive ability across psychotic disorders. 
  • Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. 
  • Diagnosing attention deficit disorders with the Behavioral Assessment System for Children and the Child Behavior Checklist: test and construct validity analyses using optimal discriminant classification trees. 
  • Diagnosing depression in patients with medical illness. 
  • Diagnosis of major depression in cancer patients according to four sets of criteria. 
  • Diagnostic accuracy of Spanish language depression-screening instruments. 
  • Diagnostic accuracy of three scoring methods for the Davidson Trauma Scale among U.S. military veterans. 
  • Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms. 
  • Diagnostic issues in posttraumatic stress disorder: considerations for the DSM-IV. 
  • Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: a pilot randomized controlled trial. 
  • Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. 
  • Differences in early childhood risk factors for juvenile-onset and adult-onset depression. 
  • Differences in psychiatric symptoms among Asian patients with depression: a multi-country cross-sectional study. 
  • Differential item functioning due to cognitive status does not impact depressive symptom measures in four heterogeneous samples of older adults. 
  • Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. 
  • Differential predictability of four dimensions of affect intensity. 
  • Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. 
  • Digital period analysis of EEG in depression: periodicity, coherence, and interhemispheric relationships during sleep. 
  • Digital period analysis of sleep EEG in depression. 
  • Disability in geriatric depression. 
  • Distinct neuronal patterns of positive and negative moral processing in psychopathy. 
  • Distributional Properties and Criterion Validity of a Shortened Version of the Social Responsiveness Scale: Results from the ECHO Program and Implications for Social Communication Research. 
  • Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. 
  • Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. 
  • Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. 
  • Divergent responses of the amygdala and ventral striatum predict stress-related problem drinking in young adults: possible differential markers of affective and impulsive pathways of risk for alcohol use disorder. 
  • Do beliefs about depression etiologies influence the type and severity of depression stigma? The case of Arab adolescents. 
  • Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. 
  • Do high-threat life events really provoke the onset of psychiatric disorder in children? 
  • Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. 
  • Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium. 
  • Does This Patient Have Posttraumatic Stress Disorder?: Rational Clinical Examination Systematic Review. 
  • Does age make a difference in the effects of physical health and social support on the outcome of a major depressive episode? 
  • Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. 
  • Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. 
  • Does pretreatment insomnia or anxiety predict acute response to bupropion SR? 
  • Does sigma receptor antagonism predict clinical antipsychotic efficacy? 
  • Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. 
  • Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. 
  • Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. 
  • Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. 
  • Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls. 
  • Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. 
  • Durability of antidepressant response to vagus nerve stimulation (VNS). 
  • Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. 
  • Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. 
  • Dynamic Resting-State Functional Connectivity in Major Depression. 
  • Dynamic systems theory as a paradigm for the study of change in psychotherapy: an application to cognitive therapy for depression. 
  • Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects. 
  • ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. 
  • ECT use in unipolar and bipolar depression. 
  • ERP responses differentiate inverted but not upright face processing in adults with ASD. 
  • Early attention problems and children's reading achievement: A longitudinal investigation 
  • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. 
  • Ecological momentary assessment of posttraumatic stress disorder symptoms during a smoking quit attempt. 
  • Editorial Comment: Is It Time to Take the "Sub" Out of Subsyndromal Depression? 
  • Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. 
  • Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial. 
  • Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. 
  • Effect of bromocriptine on affect and libido in hyperprolactinemia. 
  • Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. 
  • Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. 
  • Effect of the 5-HTTLPR polymorphism on posttraumatic stress disorder, depression, anxiety, and quality of life among Iraq and Afghanistan veterans. 
  • Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. 
  • Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. 
  • Effectiveness of a peer-delivered, psychosocial intervention on maternal depression and child development at 3 years postnatal: a cluster randomised trial in Pakistan. 
  • Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. 
  • Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. 
  • Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. 
  • Effectiveness of psychological treatments for depression and alcohol use disorder delivered by community-based counsellors: two pragmatic randomised controlled trials within primary healthcare in Nepal. 
  • Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. 
  • Effectiveness of switching from antipsychotic polypharmacy to monotherapy. 
  • Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. 
  • Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. 
  • Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. 
  • Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients. 
  • Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients. 
  • Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. 
  • Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. 
  • Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. 
  • Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. 
  • Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. 
  • Effects of fluoxetine on the polysomnogram in outpatients with major depression. 
  • Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial. 
  • Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. 
  • Effects of paroxetine and venlafaxine XR on heart rate variability in depression. 
  • Effects of posttraumatic stress disorder status and covert hostility on cardiovascular responses to relived anger in women with and without PTSD. 
  • Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. 
  • Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. 
  • Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study. 
  • Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis. 
  • Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. 
  • Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. 
  • Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. 
  • Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. 
  • Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. 
  • Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. 
  • Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. 
  • Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies. 
  • Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder. 
  • Efficacy of olanzapine in social anxiety disorder: a pilot study. 
  • Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. 
  • Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. 
  • Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder. 
  • Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. 
  • Emotion recognition and social/role dysfunction in non-clinical psychosis. 
  • Emotional learning during dissociative states in borderline personality disorder. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder. 
  • Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. 
  • Endogenous and non-endogenous depressions: relations to life events, dysfunctional attitudes and event perceptions. 
  • Epidemiology of psychiatric disorders in very young children in a Romanian pediatric setting. 
  • Escitalopram treatment of trichotillomania. 
  • Establishing the Brief Assessment of Cognition - Short form. 
  • Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease. 
  • Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. 
  • Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. 
  • Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. 
  • Evaluation of a saliva alcohol test stick as a therapeutic adjunct in an alcoholism treatment program. 
  • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. 
  • Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. 
  • Examining the Overlap Between Moral Injury and PTSD in US Veterans and Active Duty Military. 
  • Examining the association between emotion regulation difficulties and probable posttraumatic stress disorder within a sample of African Americans. 
  • Examining the inventory of interpersonal problems as a tool for conducting analogue studies of mechanisms underlying Borderline Personality Disorder. 
  • Examining the relation between posttraumatic stress disorder and suicidal ideation in an OEF/OIF veteran sample. 
  • Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. 
  • Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. 
  • Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. 
  • Exploration of the resilience construct in posttraumatic stress disorder severity and functional correlates in military combat veterans who have served since September 11, 2001. 
  • Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial. 
  • Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. 
  • Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. 
  • Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS). 
  • Eye movement impairment and schizotypal psychopathology. 
  • Eye tracking impairment in clinically identified patients with schizotypal personality disorder. 
  • Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. 
  • Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis. 
  • Factorial invariance of posttraumatic stress disorder symptoms across three veteran samples. 
  • Factors associated with caregiver burden among caregivers of children with cerebral palsy in Sri Lanka. 
  • Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report. 
  • Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. 
  • Factors that differentiate early vs. later onset of major depression disorder. 
  • Familial schizophrenia and treatment response. 
  • Family history of psychiatric disorder and low self-confidence: predictors of depressive symptoms at 12-month follow-up. 
  • Family instability and child maladjustment trajectories during elementary school 
  • Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. 
  • Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. 
  • Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. 
  • Female sexual dysfunction in patients with spinal cord injury: a study from Iran. 
  • Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. 
  • Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. 
  • Fluoxetine versus trazodone in the treatment of outpatients with major depression. 
  • Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. 
  • Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. 
  • Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. 
  • Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder. 
  • Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. 
  • Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews. 
  • Food-addiction scale measurement in 2 cohorts of middle-aged and older women. 
  • Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. 
  • Functional brain activation to emotional and nonemotional faces in healthy children: evidence for developmentally undifferentiated amygdala function during the school-age period. 
  • Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. 
  • Functional connectivity of the amygdala in early-childhood-onset depression. 
  • Functional connectivity predictors of acute depression treatment outcome. 
  • Functional disability in adolescents with orthostatic intolerance and chronic pain. 
  • Functional status in depressed patients: the relationship to disease severity and disease resolution. 
  • Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis. 
  • Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations. 
  • Genetic and hormonal sensitivity to threat: testing a serotonin transporter genotype × testosterone interaction. 
  • Gray and white matter brain volumes in older adults with bipolar disorder. 
  • Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects. 
  • Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic. 
  • HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. 
  • Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. 
  • Health behaviour, depression and religiosity in older patients admitted to intermediate care. 
  • Health impacts of caregiving for older adults with functional limitations: results from the Singapore survey on informal caregiving. 
  • Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. 
  • Health-related quality of life in depression: a STAR*D report. 
  • Health-related quality of life in older depressed psychogeriatric patients: one year follow-up. 
  • Heritability of functioning in families with schizophrenia in relation to neurocognition. 
  • Heterogeneity in symptom profiles among older adults diagnosed with major depression. 
  • High- and low-structure treatments for substance dependence: role of learned helplessness. 
  • High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. 
  • High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. 
  • Hippocampal volume in geriatric depression. 
  • Hostility and fasting glucose in African American women. 
  • How etiological explanations for depression impact perceptions of stigma, treatment effectiveness, and controllability of depression. 
  • How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS. 
  • Hyperintense lesions on magnetic resonance images in bipolar disorder. 
  • Identification of borderline personality disorder with the NIMH Diagnostic Interview Schedule. 
  • Identifying an efficient set of items sensitive to clinical-range externalizing problems in children. 
  • Identifying risk for attrition during treatment for depression. 
  • Illness specific patterns of psychological adjustment and cognitive adaptational processes in children with cystic fibrosis and sickle cell disease. 
  • Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial. 
  • Impact of depressive symptoms on the treatment of generalized social anxiety disorder. 
  • Impact of preoperative depression on 2-year clinical outcomes following adult spinal deformity surgery: the importance of risk stratification based on type of psychological distress. 
  • Impaired but undiagnosed. 
  • Impaired plasmalogens in patients with schizophrenia. 
  • Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial. 
  • Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. 
  • Increase in work productivity of depressed individuals with improvement in depressive symptom severity. 
  • Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression. 
  • Increased plasma complement factor H is associated with geriatric depression. 
  • Indicators of pretreatment suicidal ideation in adults with major depressive disorder. 
  • Individual participant data meta-analysis to compare EPDS accuracy to detect major depression with and without the self-harm item. 
  • Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. 
  • Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. 
  • Informal caregivers' burden and stress in caring for stroke survivors with spatial neglect: an exploratory mixed-method study. 
  • Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. 
  • Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use. 
  • Insight about psychosis among outpatients with schizophrenia. 
  • Insight and treatment outcome in obsessive-compulsive disorder. 
  • Insight in schizophrenia and mania. 
  • Insight is greater in mixed than in pure manic episodes of bipolar I disorder. 
  • Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? 
  • Insomnia in patients with depression: a STAR*D report. 
  • Insomnia is frequent in schizophrenia and associated with night eating and obesity. 
  • Instability in teacher ratings of children's inattentive symptoms: implications for the assessment of ADHD. 
  • Interaction between serotonin transporter polymorphism (5-HTTLPR) and stressful life events in adolescents' trajectories of anxious/depressed symptoms. 
  • Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions. 
  • Internal consistency of DSM-III diagnoses using the symptom scales of the Child Assessment Schedule. 
  • International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. 
  • Interpersonal and self-reported hostility among combat veterans with and without posttraumatic stress disorder. 
  • Interpersonal assessment of borderline personality disorder: preliminary findings. 
  • Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 
  • Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms. 
  • Intima-media thickness and age of first depressive episode. 
  • Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. 
  • Is there a definition of remission in late-life depression that predicts later relapse? 
  • Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 
  • Is this patient clinically depressed? 
  • Issues in the assessment of personality disorder and substance abuse using the Millon Clinical Multiaxial Inventory (MCMI-II). 
  • Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia. 
  • L-dopa challenge and relapse in schizophrenia. 
  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. 
  • Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. 
  • Late luteal phase dysphoric disorder. 
  • Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. 
  • Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. 
  • Latent class analysis of discordance between results of drug use assessments in the CATIE data. 
  • Latent subtypes of depression in a community sample of older adults: can depression clusters predict future depression trajectories? 
  • Learning and recall in subjects at genetic risk for Alzheimer's disease. 
  • Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls. 
  • Leisure activities, education, and cognitive impairment in Chinese older adults: a population-based longitudinal study. 
  • Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation. 
  • Levetiracetam in social phobia: a placebo controlled pilot study. 
  • Lifetime and current prevalence of specific psychiatric disorders among Vietnam veterans and controls. 
  • Lifetime trauma exposure in veterans with military-related posttraumatic stress disorder: association with current symptomatology. 
  • Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder. 
  • Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. 
  • Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study. 
  • Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. 
  • Living with genetic risk: effect on adolescent self-concept. 
  • Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN). 
  • Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial. 
  • Long-Term Outcomes of Early Intervention in 6-Year-Old Children With Autism Spectrum Disorder. 
  • Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. 
  • Long-term psychosocial effects of childhood exposure to parental problem drinking. 
  • Long-term treatment of social phobia with clonazepam. 
  • Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis. 
  • Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. 
  • Low plasma GABA is a trait-like marker for bipolar illness. 
  • Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • MRI changes in schizophrenia in late life: a preliminary controlled study. 
  • MRI signal hyperintensities in geriatric depression. 
  • MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. 
  • Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. 
  • Magnetic resonance spectroscopy in social phobia: preliminary findings. 
  • Magnetic seizure therapy of major depression. 
  • Magnetic-resonance morphometry in patients with major depression. 
  • Major depression and physical illness trajectories in heart failure and pulmonary disease. 
  • Major depression and the NIMH Diagnostic Interview Schedule: validation in medically ill hospitalized patients. 
  • Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS. 
  • Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. 
  • Masculine Traits and Depressive Symptoms in Older and Younger Men and Women. 
  • Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. 
  • Measuring addiction propensity and severity: the need for a new instrument. 
  • Medical comorbidity in a bipolar outpatient clinical population. 
  • Medically unexplained physical symptoms, somatization disorder and abridged somatization: studies with the Diagnostic Interview Schedule. 
  • Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. 
  • Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. 
  • Meeting of minds in psychiatry and homeopathy: an example in social phobia. 
  • Melancholic symptom features and DSM-IV. 
  • Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. 
  • Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. 
  • Metabolomic mapping of atypical antipsychotic effects in schizophrenia. 
  • Methodological issues in negative symptom trials. 
  • Methodology and preliminary results from the neurobiology of late-life depression study. 
  • Methods to improve diagnostic accuracy in a community mental health setting. 
  • Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. 
  • Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. 
  • Mindfulness, Self-Compassion, Posttraumatic Stress Disorder Symptoms, and Functional Disability in U.S. Iraq and Afghanistan War Veterans. 
  • Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. 
  • Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. 
  • Minor depression and physical outcome trajectories in heart failure and pulmonary disease. 
  • Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. 
  • Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. 
  • Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. 
  • Moclobemide in social phobia: a controlled dose-response trial. 
  • Modulation of a human memory circuit by subsyndromal depression in late life: a functional magnetic resonance imaging study. 
  • Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). 
  • Moral Injury and Religiosity in US Veterans With Posttraumatic Stress Disorder Symptoms. 
  • Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. 
  • Mother-child agreement on the child assessment schedule with nonreferred children: a research note. 
  • Motor cortex excitability after vagus nerve stimulation in major depression. 
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. 
  • Naltrexone in patients with bipolar disorder and alcohol dependence. 
  • National dissemination of cognitive-behavioral therapy for chronic pain in veterans: therapist and patient-level outcomes. 
  • National dissemination of interpersonal psychotherapy for depression in veterans: therapist and patient-level outcomes. 
  • Neighborhood characteristics moderate effects of caregiving on glucose functioning. 
  • Neighborhood health center patients who use minor tranquilizers. 
  • Neighborhood language isolation and depressive symptoms among elderly U.S. Latinos. 
  • Neural correlates of automatic and controlled auditory processing in schizophrenia. 
  • Neural correlates of face and object recognition in young children with autism spectrum disorder, developmental delay, and typical development. 
  • Neural correlates of food addiction. 
  • Neural correlates of mindfulness meditation-related anxiety relief. 
  • Neural mechanisms mediating contingent capture of attention by affective stimuli. 
  • Neurobehavioral functioning and survival following lung transplantation. 
  • Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men. 
  • Neurocognitive subgroups in major depressive disorder. 
  • Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. 
  • Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. 
  • Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. 
  • Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. 
  • Neuropsychological findings in pediatric maltreatment: relationship of PTSD, dissociative symptoms, and abuse/neglect indices to neurocognitive outcomes. 
  • Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. 
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. 
  • Neuropsychological status of subjects at high risk for a first episode of psychosis. 
  • Neutrophil beta2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls. 
  • New version of brief depression scale. 
  • Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). 
  • Nicotine effects on adults with attention-deficit/hyperactivity disorder. 
  • Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. 
  • Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. 
  • Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). 
  • Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. 
  • Objective assessment of peritraumatic dissociation: psychophysiological indicators. 
  • Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. 
  • Occurrence and correlates of postpartum depression in overweight and obese women: results from the active mothers postpartum (AMP) study. 
  • Olanzapine and haloperidol in first episode psychosis: two-year data. 
  • Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. 
  • On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression. 
  • One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. 
  • One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. 
  • One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes. 
  • Onset and persistence of postpartum depression in an inner-city maternal health clinic system. 
  • Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. 
  • Open trial of nefazodone for combat-related posttraumatic stress disorder. 
  • Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. 
  • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. 
  • Osteoporosis and depression: shedding more light upon a complex relationship. 
  • Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. 
  • Over and over again: rumination, reflection, and promotion goal failure and their interactive effects on depressive symptoms. 
  • PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients. 
  • PTSD and substance abuse. 
  • Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Parental agreement of reporting parent to child aggression using the Conflict Tactics Scales 
  • Parental marital discord and treatment response in depressed adolescents. 
  • Parental relationships and behavioral approach system dysregulation in young adults with bipolar disorder. 
  • Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. 
  • Paroxetine as a treatment for premenstrual dysphoric disorder. 
  • Partial REM sleep deprivation, schizophrenia and field articulation. 
  • Pathways to PTSD, part II: Sexually abused children. 
  • Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. 
  • Patient-controlled analgesia in postoperative pain: the relation of psychological factors to pain and analgesic use. 
  • Patients with depression and anxiety symptoms from adjustment disorder related to their shoulder may be ideal patients for arthroscopic rotator cuff repair. 
  • Patterns of appraisal and coping across different stressor conditions among former prisoners of war with and without posttraumatic stress disorder. 
  • Peer victimization during middle childhood as a lead indicator of internalizing problems and diagnostic outcomes in late adolescence. 
  • Perceived discrimination, humiliation, and mental health: a mixed-methods study among Haitian migrants in the Dominican Republic. 
  • Perceived parental burden and service use for child and adolescent psychiatric disorders. 
  • Perception of unmet basic needs as a predictor of depressive symptoms among community-dwelling older adults. 
  • Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. 
  • Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis. 
  • Perinatal western-type diet and associated gestational weight gain alter postpartum maternal mood. 
  • Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. 
  • Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Pharmacotherapy of impaired affect in recovering schizophrenic patients. 
  • Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. 
  • Phobia: prevalence and risk factors. 
  • Physical frailty in late-life depression is associated with deficits in speed-dependent executive functions. 
  • Physician Well-Being: Organizational Strategies for Physician Burnout. 
  • Physiological and psychosocial factors that predict HIV-related fatigue. 
  • Pilot Trial of a Combined Cognitive Processing Therapy and Smoking Cessation Treatment. 
  • Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. 
  • Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study. 
  • Platelet alpha2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls. 
  • Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome. 
  • Political violence and mental health in Nepal: prospective study. 
  • Polysomnographic findings in recently drug-free and clinically remitted depressed patients. 
  • Possible bipolar nature of irritability in major depressive disorder. 
  • Post-traumatic stress disorder. 
  • Posttraumatic Symptom Reporting and Reported Cigarette Smoking During Pregnancy. 
  • Posttraumatic growth in treatment-seeking female assault victims. 
  • Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. 
  • Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. 
  • Posttraumatic stress without trauma in children. 
  • Practical assessment and evaluation of mental health problems following a mass disaster. 
  • Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data. 
  • Predicting response to amitriptyline in posttraumatic stress disorder. 
  • Predicting the risk of future depression among school-attending adolescents in Nigeria using a model developed in Brazil. 
  • Prediction from low birth weight to female adolescent depression: a test of competing hypotheses. 
  • Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials. 
  • Prediction of differential adult health burden by conduct problem subtypes in males. 
  • Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. 
  • Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder. 
  • Predictors of antidepressant use among older adults: have they changed over time? 
  • Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. 
  • Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention. 
  • Predictors of nonresponse to treatment in primary care patients with dysthymia. 
  • Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake. 
  • Predictors of response to monoamine oxidase inhibitors: do they exist? 
  • Predictors of therapeutic response to haloperidol in acute schizophrenia. 
  • Prefrontal neuropsychological predictors of treatment remission in late-life depression. 
  • Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. 
  • Pregabalin in generalized anxiety disorder: a placebo-controlled trial. 
  • Preliminary Evaluation of a Modified STarT Back Screening Tool Across Different Musculoskeletal Pain Conditions. 
  • Preliminary structural MRI based brain classification of chronic pelvic pain: A MAPP network study. 
  • Presence of neuroticism and antidepressant remission rates in late-life depression: results from the Neurobiology of Late-Life Depression (NBOLD) study. 
  • Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. 
  • Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. 
  • Prevalence and Predictors of Moral Injury Symptoms in Health Care Professionals. 
  • Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. 
  • Prevalence and factors associated with antenatal depressive symptoms among women enrolled in Option B+ antenatal HIV care in Malawi: a cross-sectional analysis. 
  • Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi. 
  • Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis. 
  • Prevalence of Cognitive Impairment and Dementia in Malays - Epidemiology of Dementia in Singapore Study. 
  • Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. 
  • Prevalence of depression and its treatment in an elderly population: the Cache County study. 
  • Prevalence of psychiatric disorders among incarcerated women. II. Convicted felons entering prison. 
  • Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. 
  • Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. 
  • Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial. 
  • Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. 
  • Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. 
  • Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. 
  • Problems associated with the diagnosis of depression. 
  • Profiles of depressive symptoms in older adults diagnosed with major depression: latent cluster analysis. 
  • Profiling posttraumatic functional impairment. 
  • Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. 
  • Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. 
  • Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. 
  • Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury. 
  • Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. 
  • Promoting supportive parenting in new mothers with substance-use problems: a pilot randomized trial of residential treatment plus an attachment-based parenting program. 
  • Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia. 
  • Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. 
  • Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. 
  • Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. 
  • Psychiatric and medical comorbidities of bipolar disorder. 
  • Psychiatric assessment of young children. 
  • Psychiatric disorder and quality of life in patients awaiting lung transplantation. 
  • Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. 
  • Psychiatric disorder, impairment, and service use in rural African American and white youth. 
  • Psychiatric disorders in pediatric primary care. Prevalence and risk factors. 
  • Psychological correlates of obese patients seeking surgical or residential behavioral weight loss treatment. 
  • Psychological distress and associated factors among kidney transplant recipients and living kidney donors during COVID-19. 
  • Psychological inflexibility predicts PTSD symptom severity in war veterans after accounting for established PTSD risk factors and personality. 
  • Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members. 
  • Psychometric properties of the Iranian version of the female sexual distress scale-revised in women. 
  • Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. 
  • Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. 
  • Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. 
  • Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. 
  • Psychopathology in pediatric primary care: the new hidden morbidity. 
  • Psychosocial concerns and health-compromising behaviors among overweight and nonoverweight adolescents. 
  • Psychosocial factors in low back pain: letting go of our misconceptions can help management. 
  • Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. 
  • Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? 
  • Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. 
  • Qualitative examination of cognitive change during PTSD treatment for active duty service members. 
  • Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study. 
  • Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. 
  • Race, psychosocial vulnerability and social support differences in inner-city women's symptoms of posttraumatic stress disorder. 
  • Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. 
  • Randomized controlled trial of acceptance and commitment therapy for distress and impairment in OEF/OIF/OND veterans. 
  • Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. 
  • Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. 
  • Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. 
  • Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. 
  • Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. 
  • Recurrent brief depression: a DSM-IV perspective. 
  • Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care. 
  • Reduced amygdala response in youths with disruptive behavior disorders and psychopathic traits: decreased emotional response versus increased top-down attention to nonemotional features. 
  • Reduced amygdala-orbitofrontal connectivity during moral judgments in youths with disruptive behavior disorders and psychopathic traits. 
  • Reduced comparison speed during visual search in late life depression. 
  • Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study. 
  • Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. 
  • Reduction of orbital frontal cortex volume in geriatric depression. 
  • Refining criteria for posttraumatic stress disorder. 
  • Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. 
  • Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report. 
  • Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. 
  • Relation between informant-rated personality and clinician-rated depression in patients with memory disorders. 
  • Relation of serum valproate concentration to response in mania. 
  • Relationship Among Koenig Depression Scale and Postoperative Outcomes, Ambulation, and Perception of Pain in Elderly Patients (≥65 Years) Undergoing Elective Spinal Surgery for Adult Scoliosis. 
  • Relationship between coping and depression in heart transplant candidates and their spouses. 
  • Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. 
  • Relationship of ethnicity, gender, and ambulatory blood pressure to pain sensitivity: effects of individualized pain rating scales. 
  • Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. 
  • Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. 
  • Relationship of trauma symptoms to amygdala-based functional brain changes in adolescents. 
  • Relationships Between Maltreatment, Posttraumatic Symptomatology, and the Dissociative Subtype of PTSD Among Adolescents. 
  • Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. 
  • Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. 
  • Relationships of maternal folate and vitamin B12 status during pregnancy with perinatal depression: The GUSTO study. 
  • Relative impact of maternal depression and associated risk factors on offspring psychopathology. 
  • Relaxation therapy reduces anxiety in child and adolescent psychiatric patients. 
  • Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia. 
  • Reliability and validity of self- and other-ratings of symptoms of ADHD in adults. 
  • Reliability and validity of the SF-12 health survey among people with severe mental illness. 
  • Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. 
  • Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. 
  • Religion and remission of depression in medical inpatients with heart failure/pulmonary disease. 
  • Religiosity and mental health in southern, community-dwelling older adults. 
  • Religiosity, depression and telomere length in Chinese older adults. 
  • Religiosity/spirituality and pain in patients with sickle cell disease. 
  • Religious affiliation and psychiatric disorder among Protestant baby boomers. 
  • Religious attendance reduces cognitive decline among older women with high levels of depressive symptoms. 
  • Religious attitudes and practices of hospitalized medically ill older adults. 
  • Religiousness affects mental health, pain and quality of life in older people in an outpatient rehabilitation setting. 
  • Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale. 
  • Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR. 
  • Repairing the shattered self: recovering from trauma. 
  • Repetitive Transcranial Magnetic Stimulation of the Supplementary Motor Area in the treatment of Tourette Syndrome: report of two cases. 
  • Residual symptoms following empirically supported treatment for PTSD. 
  • Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. 
  • Residual symptoms in older patients treated for major depression. 
  • Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. 
  • Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression? 
  • Response inhibition and everyday memory complaints in older adult women. 
  • Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? 
  • Responses to hypercarbia induced by acetazolamide in panic disorder patients. 
  • Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. 
  • Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder. 
  • Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. 
  • Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls. 
  • Retrograde amnesia with electroconvulsive therapy: characteristics and implications. 
  • Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. 
  • Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. 
  • Risk of spontaneous preterm birth in relation to maternal depressive, anxiety, and stress symptoms. 
  • Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. 
  • Risperidone use in autism spectrum disorders: a retrospective review of a clinic-referred patient population. 
  • Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. 
  • Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. 
  • Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children--a preliminary psychometric study. 
  • Schema therapy, motivational interviewing, and collaborative-mapping as treatment for depression among low income, second generation Latinas. 
  • Scoring nonresponse on the Mini-Mental State Examination. 
  • Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. 
  • Screening for DSM-IV externalizing disorders with the Child Behavior Checklist: a receiver-operating characteristic analysis. 
  • Screening for behavioral and emotional problems in primary care pediatrics. 
  • Screening for child-reported behavioral and emotional problems in primary care pediatrics. 
  • Screening for cognitive impairment: comparing the performance of four instruments in primary care. 
  • Screening for depression in hospitalized elderly medical patients: taking a closer look. 
  • Screening for major depression in private practice. 
  • Screening for postnatal depression in Chinese-speaking women using the Hong Kong translated version of the Edinburgh Postnatal Depression Scale. 
  • Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II. 
  • Secretive eating among youth with overweight or obesity. 
  • Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. 
  • Selecting methodologies for the evaluation of differences in time to response between antidepressants. 
  • Selective cutoff reporting in studies of the accuracy of the Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale: Comparison of results based on published cutoffs versus all cutoffs using individual participant data meta-analysis. 
  • Selective serotonin reuptake inhibitors in post-traumatic stress disorder. 
  • Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial. 
  • Self-Compassion as a prospective predictor of PTSD symptom severity among trauma-exposed U.S. Iraq and Afghanistan war veterans. 
  • Self-efficacy and pain behavior among subjects with fibromyalgia. 
  • Self-focused attention in anorexia nervosa. 
  • Self-help on-line: an outcome evaluation of breast cancer bulletin boards. 
  • Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. 
  • Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. 
  • Sensitivity and specificity of cognitive and functional screening instruments for dementia: the Indo-U.S. Dementia Epidemiology Study. 
  • Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. 
  • Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis. 
  • Sensitivity of the dementia rating scale in vascular dementia: comparison between two sets of criteria to define cognitive impairment. 
  • Separating the domains of oppositional behavior: comparing latent models of the conners' oppositional subscale. 
  • Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. 
  • Sertraline Pediatric Registry for the Evaluation of Safety: Design and Clinical Characteristics of Pediatric Patients Prescribed Sertraline. 
  • Sertraline and the Cheshire cat in geriatric depression. 
  • Sertraline versus imipramine to prevent relapse in chronic depression. 
  • Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment. 
  • Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. 
  • Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. 
  • Sex and depression in the National Comorbidity Survey. II: Cohort effects. 
  • Sex differences in response to citalopram: a STAR*D report. 
  • Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. 
  • Sex differences in the relationship between subthreshold depression and mortality in a community sample of older adults. 
  • Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. 
  • Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. 
  • Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. 
  • Short-term psychotherapy of depressive disorders: current status and future directions. 
  • Shortening the Edinburgh postnatal depression scale using optimal test assembly methods: Development of the EPDS-Dep-5. 
  • Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients? 
  • Sickness response symptoms among healthy volunteers after controlled exposures to diesel exhaust and psychological stress. 
  • Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. 
  • Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy. 
  • Sleep difficulties and alcohol use motives in female rape victims with posttraumatic stress disorder. 
  • Sleep disturbance in euthymic bipolar patients. 
  • Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis. 
  • Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression. 
  • Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. 
  • Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. 
  • Smaller orbital frontal cortex volumes associated with functional disability in depressed elders. 
  • Smoking and psychosis in patients with bipolar I disorder. 
  • Smoking withdrawal symptoms in response to a trauma-related stressor among Vietnam combat veterans with posttraumatic stress disorder. 
  • Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment. 
  • Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. 
  • Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis. 
  • Social impairments in alternating hemiplegia of childhood. 
  • Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents. 
  • Social phobia: biological aspects and pharmacotherapy. 
  • Social phobia: issues in assessment and management. 
  • Social problem-solving among adolescents treated for depression. 
  • Social skills, negative symptoms and real-world functioning in individuals at ultra-high risk of psychosis. 
  • Social stimulation and joint attention in young autistic children. 
  • Social support in late life mania: GERI-BD. 
  • Social support modifies the relationship between personality and depressive symptoms in older adults. 
  • Socio-environmental risks for untreated depression among formerly incarcerated Latino men. 
  • Sociodemographic and clinical predictors of mortality in geriatric depression. 
  • Socioeconomic status as a moderator of ADHD treatment outcomes. 
  • Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches. 
  • Somatization disorder in the community. A study of diagnostic concordance among three diagnostic systems. 
  • Somatization in the conceptualization of sickle cell disease. 
  • Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. 
  • Spectral and topographic analysis of EEG in schizophrenic patients. 
  • Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. 
  • Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population. 
  • State of the science in autism: report to the National Institutes Health. 
  • Status of minor depression or dysthymia in primary care following a randomized controlled treatment. 
  • Stimulant treatment for children: a community perspective. 
  • Strategies for assessing mental health in Haiti: local instrument development and transcultural translation. 
  • Stress and coping in caregivers of patients awaiting solid organ transplantation. 
  • Stress reactivity and coping in seasonal and nonseasonal depression. 
  • Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis. 
  • Structure and measurement of depression in youths: applying item response theory to clinical data. 
  • Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department. 
  • Structured interview and uniform assessment improves diagnostic reliability. 
  • Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria. 
  • Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. 
  • Subcomponents of psychopathy have opposing correlations with punishment judgments. 
  • Subgrouping for patients with low back pain: a multidimensional approach incorporating cluster analysis and the STarT Back Screening Tool. 
  • Subjective cognitive function and decline among older adults with psychometrically defined amnestic MCI. 
  • Subtypes of depression in patients with chronic pain. 
  • Subtypes of mania determined by grade of membership analysis. 
  • Suicidal Ideation is Associated with Limited Engagement in HIV Care. 
  • Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation. 
  • Suicidal or self-harming ideation in military personnel transitioning to civilian life. 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. 
  • Symptom features of postpartum depression: are they distinct? 
  • Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. 
  • Symptom-specific effects of fluoxetine in post-traumatic stress disorder. 
  • Symptomatic and functional assessment of social anxiety disorder in adults. 
  • Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. 
  • Symptoms of interpersonal sensitivity in depression. 
  • Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use. 
  • Temporo-parietal junction stimulation in the treatment of depersonalization disorder. 
  • The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia. 
  • The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. 
  • The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis. 
  • The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. 
  • The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. 
  • The Brief Social Phobia Scale. 
  • The Brief Social Phobia Scale: a psychometric evaluation. 
  • The Center for Epidemiological Studies-Depression (CES-D) Scale: assessment of depression in the medically ill elderly. 
  • The Child and Adolescent Psychiatric Assessment (CAPA). 
  • The Child and Adolescent Psychiatric Assessment (CAPA). 
  • The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients. 
  • The Coping Strategies Questionnaire: a large sample, item level factor analysis. 
  • The DST and posttraumatic stress disorder. 
  • The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. 
  • The Dissociative Subtype of Posttraumatic Stress Disorder (PTSD) Among Adolescents: Co-Occurring PTSD, Depersonalization/Derealization, and Other Dissociation Symptoms. 
  • The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. 
  • The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study. 
  • The Evaluation of Baseline Physical Function and Cognition in Women Undergoing Pelvic Floor Surgery. 
  • The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States. 
  • The Invalidating Childhood Environment Scale (ICES): psychometric properties and relationship to borderline personality symptomatology. 
  • The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. 
  • The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective. 
  • The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. 
  • The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. 
  • The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. 
  • The Montgomery-Asberg Depression Scale: reliability and validity. 
  • The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. 
  • The Newcastle Endogenous Depression Diagnostic Index: validity and reliability. 
  • The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. 
  • The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. 
  • The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration. 
  • The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder. 
  • The Relation of Light-to-Moderate Alcohol Consumption to Glucose Metabolism and Insulin Resistance in Nondiabetic Adults: the Moderating Effects of Depressive Symptom Severity, Adiposity, and Sex. 
  • The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. 
  • The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. 
  • The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. 
  • The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. 
  • The US National Comorbidity Survey: overview and future directions. 
  • The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism. 
  • The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. 
  • The age at onset of attention deficit hyperactivity disorder. 
  • The association between depressive symptoms and mortality among older participants in the Epidemiologic Catchment Area-Piedmont Health Survey. 
  • The association between intravenous iron for antenatal anemia and postnatal depression: a retrospective cohort study. 
  • The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects. 
  • The association between spiritual and religious involvement and depressive symptoms in a Canadian population. 
  • The association between weight change and symptom reduction in the CATIE schizophrenia trial. 
  • The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. 
  • The association of psychosocial factors and depression with hypertension among older adults. 
  • The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. 
  • The association of sexual assault and attempted suicide within the community. 
  • The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder. 
  • The caregiving environments provided to children by depressed mothers with or without an antisocial history. 
  • The centrality of event scale: a measure of integrating a trauma into one's identity and its relation to post-traumatic stress disorder symptoms. 
  • The complex relationship between depressive symptoms and functional limitations in community-dwelling older adults: the impact of subthreshold depression. 
  • The comprehensive assessment of community dwelling elderly: why functional status is not enough. 
  • The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. 
  • The course of postdisaster psychiatric disorders in directly exposed civilians after the US Embassy bombing in Nairobi, Kenya: a follow-up study. 
  • The development of socioeconomic inequalities in anxiety and depression symptoms over the lifecourse. 
  • The dexamethasone suppression test in patients with mood disorders. 
  • The effect of acute tryptophan depletion on emotional distraction and subsequent memory. 
  • The effect of different diagnostic criteria on the prevalence of dementia. 
  • The effect of neuroticism on the recall of persistent low-back pain and perceived activity interference. 
  • The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder. 
  • The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation. 
  • The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. 
  • The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. 
  • The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. 
  • The effects of electroconvulsive therapy on memory of autobiographical and public events. 
  • The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. 
  • The efficacy of acute electroconvulsive therapy in atypical depression. 
  • The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. 
  • The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. 
  • The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. 
  • The empirical identification of insomnia subtypes: a cluster analytic approach. 
  • The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. 
  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. 
  • The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study. 
  • The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. 
  • The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. 
  • The impact of childhood abuse among women with assault-related PTSD receiving short-term cognitive-behavioral therapy. 
  • The impact of nonclinical factors on care use for patients with depression: a STAR*D report. 
  • The importance of dose in isocarboxazid therapy. 
  • The incidence of mental and behavioral disturbances in dementia: the cache county study. 
  • The latent class structure of ADHD is stable across informants. 
  • The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18. 
  • The many methods of religious coping: development and initial validation of the RCOPE. 
  • The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. 
  • The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. 
  • The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. 
  • The prevalence of potentially traumatic events in childhood and adolescence. 
  • The quick inventory of depressive symptomatology (clinician and self-report versions) in patients with bipolar disorder. 
  • The relation between insecure attachment and posttraumatic stress: Early life versus adulthood traumas. 
  • The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. 
  • The relationship between holding back from communicating about breast concerns and anxiety in the year following breast biopsy. 
  • The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services. 
  • The relationship between spirituality and depressive symptoms: testing psychosocial mechanisms. 
  • The relationship of aging and dysthymia in primary care. 
  • The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. 
  • The relationship of two types of trauma exposure to current physical and psychological symptom distress in a community sample of Colombian women: Why interpersonal violence deserves more attention 
  • The relative ability of three ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. 
  • The response of depressed inpatients to isocarboxazid. 
  • The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa. 
  • The roles of anxiety and depression in connecting tic severity and functional impairment. 
  • The screening and diagnosis of autistic spectrum disorders. 
  • The spectrum of quality-of-life impairments in recurrent geriatric depression. 
  • The structure and stability of common mental disorders (DSM-III-R): a longitudinal-epidemiological study. 
  • The treatment effectiveness project. A comparison of the effectiveness of paroxetine, problem-solving therapy, and placebo in the treatment of minor depression and dysthymia in primary care patients: background and research plan. 
  • The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. 
  • The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. 
  • The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? 
  • The undertreatment of dysthymia. 
  • The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. 
  • The use of mental health measures in nursing home research. 
  • The use of the Minimum Data Set to identify depression in the elderly. 
  • The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. 
  • The utility of the Beck Depression Inventory in a bariatric surgery population. 
  • Thematic resolution, PTSD, and complex PTSD: the relationship between meaning and trauma-related diagnoses. 
  • Therapeutic Alliance between the Caregivers of Critical Illness Survivors and Intensive Care Unit Clinicians. 
  • Thought suppression and treatment outcome in late-life depression. 
  • Thresholds and accuracy in screening tools for early detection of psychopathology. 
  • Throwing down the gauntlet: can we do better than the MMSE? 
  • Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women. 
  • Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. 
  • Time course of treatment dropout in cognitive-behavioral therapies for posttraumatic stress disorder. 
  • Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. 
  • Time-to-remission from geriatric depression: psychosocial and clinical factors. 
  • Tourettism and dystonia after subcortical stroke. 
  • Toward a Definition of "No Meaningful Benefit" From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales. 
  • Toward a generalizable model of symptoms in major depressive disorder. 
  • Toward establishing an empirical basis for the diagnosis of oppositional defiant disorder. 
  • Trajectories of Depressive Symptoms Among a Population of HIV-Infected Men and Women in Routine HIV Care in the United States. 
  • Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months. 
  • Trajectories of depressive symptoms over 2 years postpartum among overweight or obese women. 
  • Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial. 
  • Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. 
  • Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. 
  • Trauma cognitions are related to symptoms up to 10 years after cognitive behavioral treatment for posttraumatic stress disorder. 
  • Trauma reactivity, avoidant coping, and PTSD symptoms: a moderating relationship? 
  • Traumatic events and posttraumatic stress in childhood. 
  • Treatment algorithm use to optimize management of symptomatic patients with a history of mania. 
  • Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. 
  • Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach. 
  • Treatment of posttraumatic stress disorder reduces suicidal ideation. 
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo. 
  • Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. 
  • Treatment of social phobia with benzodiazepines. 
  • Treatment of social phobia with clonazepam and placebo. 
  • Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. 
  • Twenty-year depressive trajectories among older women. 
  • Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. 
  • Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents. 
  • Unirhinal olfactory function in schizophrenia patients and first-degree relatives. 
  • Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia. 
  • Unraveling the relationship between obesity, schizophrenia and cognition. 
  • Use of phenelzine in continuation therapy. 
  • Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain. 
  • Use, persistence, and intensity: patterns of care for children's mental health across one year. 
  • Usefulness of the Patient Health Questionnaire-9 for Korean medical students. 
  • Using discriminant function analysis with clinical, demographic and historical variables to diagnose schizophrenia. 
  • Using effort-reward imbalance theory to understand high rates of depression and anxiety among clergy. 
  • Using self-reported callous-unemotional traits to cross-nationally assess the DSM-5 'With Limited Prosocial Emotions' specifier. 
  • Utility of the SCL-90-R with depressed and conduct-disordered adolescent inpatients. 
  • Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. 
  • Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. 
  • Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. 
  • Vagus nerve stimulation is associated with mood improvements in epilepsy patients. 
  • Validation of a Computerized test of Functional Capacity. 
  • Validation of a cross-cultural instrument for child behavior problems: the Disruptive Behavior International Scale - Nepal version. 
  • Validation of cross-cultural child mental health and psychosocial research instruments: adapting the Depression Self-Rating Scale and Child PTSD Symptom Scale in Nepal. 
  • Validation of depression screening scales in patients with CKD. 
  • Validation of four definitions of melancholia by the dexamethasone suppression test. 
  • Validation of the Davidson Trauma Scale in a sample of survivors of childhood sexual abuse. 
  • Validation of the Kriol and Belizean English Adaptation of the Revised Children's Anxiety and Depression Scale for Use With Adolescents in Belize. 
  • Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia. 
  • Validation of the Purdue Post-Traumatic Stress Scale on a sample of Vietnam veterans. 
  • Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. 
  • Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. Experience with a structured interview. 
  • Validity of DSM-IV conduct disorder in 41/2-5-year-old children: a longitudinal epidemiological study. 
  • Variability in emotional responsiveness and coping style during active avoidance as a window onto psychological vulnerability to stress. 
  • Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. 
  • Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. 
  • Ventricular enlargement in poor-outcome schizophrenia. 
  • Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers. 
  • Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning. 
  • What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? 
  • What do childhood anxiety disorders predict? 
  • What is PDDNOS and how is it diagnosed? Pervasive Developmental Disorder Not Otherwise Specified. 
  • What is generalized anxiety disorder? 
  • What predicts attrition in second step medication treatments for depression?: a STAR*D Report. 
  • What symptoms of depression predict mortality in community-dwelling elders? 
  • What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study. 
  • Which depressed patients respond to nefazodone and when? 
  • Which depressions respond to placebo? 
  • Which domains of spirituality are associated with anxiety and depression in patients with advanced illness? 
  • Which endogenous depressive symptoms relate to REM latency reduction? 
  • White matter hyperintensity progression and late-life depression outcomes. 
  • Whither psychiatric diagnosis. 
  • Who is adherent with preoperative psychological treatment recommendations among weight loss surgery candidates? 
  • Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? 
  • Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale. 
  • Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. 
• 

  Keywords of People

  • Bradford, Daniel William, Professor of Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health & Community Psychiatry
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Kimbrel, Nathan Andrew, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Nieuwsma, Jason A, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Sinnott-Armstrong, Walter, Chauncey Stillman Distinguished Professor of Practical Ethics, Duke Science & Society
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine